These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 28730968)

  • 1. Modulation of the Immune System for the Treatment of Glaucoma.
    Bell K; Und Hohenstein-Blaul NVT; Teister J; Grus F
    Curr Neuropharmacol; 2018; 16(7):942-958. PubMed ID: 28730968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune response after intermittent minimally invasive intraocular pressure elevations in an experimental animal model of glaucoma.
    Gramlich OW; Teister J; Neumann M; Tao X; Beck S; von Pein HD; Pfeiffer N; Grus FH
    J Neuroinflammation; 2016 Apr; 13(1):82. PubMed ID: 27090083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced insight into the autoimmune component of glaucoma: IgG autoantibody accumulation and pro-inflammatory conditions in human glaucomatous retina.
    Gramlich OW; Beck S; von Thun Und Hohenstein-Blaul N; Boehm N; Ziegler A; Vetter JM; Pfeiffer N; Grus FH
    PLoS One; 2013; 8(2):e57557. PubMed ID: 23451242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adaptive Immunity: New Aspects of Pathogenesis Underlying Neurodegeneration in Glaucoma and Optic Neuropathy.
    Jiang S; Kametani M; Chen DF
    Front Immunol; 2020; 11():65. PubMed ID: 32117239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of the endothelin A (ET
    McGrady NR; Minton AZ; Stankowska DL; He S; Jefferies HB; Krishnamoorthy RR
    BMC Neurosci; 2017 Mar; 18(1):27. PubMed ID: 28249604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does autoimmunity play a part in the pathogenesis of glaucoma?
    Bell K; Gramlich OW; Von Thun Und Hohenstein-Blaul N; Beck S; Funke S; Wilding C; Pfeiffer N; Grus FH
    Prog Retin Eye Res; 2013 Sep; 36():199-216. PubMed ID: 23541978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers for glaucoma: from the lab to the clinic.
    Von Thun Und Hohenstein-Blaul N; Kunst S; Pfeiffer N; Grus FH
    Eye (Lond); 2017 Feb; 31(2):225-231. PubMed ID: 28085137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In a novel autoimmune and high-pressure glaucoma model a complex immune response is induced.
    Reinehr S; Wulf J; Theile J; Schulte KK; Peters M; Fuchshofer R; Dick HB; Joachim SC
    Front Immunol; 2024; 15():1296178. PubMed ID: 38515755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glaucoma.
    Tezel G; Wax MB
    Chem Immunol Allergy; 2007; 92():221-227. PubMed ID: 17264498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmune aspects in glaucoma.
    Von Thun Und Hohenstein-Blaul N; Bell K; Pfeiffer N; Grus FH
    Eur J Pharmacol; 2016 Sep; 787():105-18. PubMed ID: 27090926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance of retinal ganglion cells to an increase in intraocular pressure is immune-dependent.
    Bakalash S; Kipnis J; Yoles E; Schwartz M
    Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2648-53. PubMed ID: 12147598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Aiming for zero blindness].
    Nakazawa T
    Nippon Ganka Gakkai Zasshi; 2015 Mar; 119(3):168-93; discussion 194. PubMed ID: 25854109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pathogenesis of glaucoma in the interplay with the immune system.
    Rieck J
    Invest Ophthalmol Vis Sci; 2013 Mar; 54(3):2393-409. PubMed ID: 23539162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoregulation of retinal ganglion cell fate in glaucoma.
    Wax MB; Tezel G
    Exp Eye Res; 2009 Apr; 88(4):825-30. PubMed ID: 19233171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The immune system and glaucoma.
    Tezel G; Wax MB
    Curr Opin Ophthalmol; 2004 Apr; 15(2):80-4. PubMed ID: 15021215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoreactive antibodies and loss of retinal ganglion cells in rats induced by immunization with ocular antigens.
    Laspas P; Gramlich OW; Müller HD; Cuny CS; Gottschling PF; Pfeiffer N; Dick HB; Joachim SC; Grus FH
    Invest Ophthalmol Vis Sci; 2011 Nov; 52(12):8835-48. PubMed ID: 22003114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene Therapy Strategies for Glaucomatous Neurodegeneration.
    Lani-Louzada R; Dias MS; Linden R; Ribas VT; Petrs-Silva H
    Curr Gene Ther; 2021; 21(5):362-381. PubMed ID: 33573569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinal Microglia in Glaucoma.
    Wang JW; Chen SD; Zhang XL; Jonas JB
    J Glaucoma; 2016 May; 25(5):459-65. PubMed ID: 25646715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination for protection of retinal ganglion cells against death from glutamate cytotoxicity and ocular hypertension: implications for glaucoma.
    Schori H; Kipnis J; Yoles E; WoldeMussie E; Ruiz G; Wheeler LA; Schwartz M
    Proc Natl Acad Sci U S A; 2001 Mar; 98(6):3398-403. PubMed ID: 11248090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time-dependent retinal ganglion cell loss, microglial activation and blood-retina-barrier tightness in an acute model of ocular hypertension.
    Trost A; Motloch K; Bruckner D; Schroedl F; Bogner B; Kaser-Eichberger A; Runge C; Strohmaier C; Klein B; Aigner L; Reitsamer HA
    Exp Eye Res; 2015 Jul; 136():59-71. PubMed ID: 26001526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.